+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
United States Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests- Product Image
United States Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests- Product Image
New

United States Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

  • PDF Icon

    Report

  • 36 Pages
  • June 2025
  • Region: United States
  • GlobalData
  • ID: 6108280
Description Jump to:
The “United States Metabolic Disorders Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Diabetes Assays and Cholesterol Tests

The United States Metabolic Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Metabolic Disorders Market.
  • Global corporate-level profiles of key companies operating within the United States Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Metabolic Disorders is segmented as follows:

  • Diabetes Assays
  • Cholesterol Tests

Reasons to Buy

The United States Metabolic Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Metabolic Disorders Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Metabolic Disorders Market, United States
3.1 Metabolic Disorders Market, United States, Revenue ($m), 2018-2033
3.1.1 Cholesterol Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Diabetes Assays Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Metabolic Disorders Market, United States, Volume (Units), 2018-2033
3.2.1 Cholesterol Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Diabetes Assays Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Metabolic Disorders Market, United States, Average Price ($), 2018-2033
3.4 Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Metabolic Disorders Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Siemens Healthineers AG
4.2.1 Company Overview
4.3 Beckman Coulter Inc
4.3.1 Company Overview
4.4 Ortho Clinical Diagnostics Holdings Plc
4.4.1 Company Overview
4.5 Roche Diagnostics International Ltd
4.5.1 Company Overview
4.6 Bio-Rad Laboratories Inc
4.6.1 Company Overview
5 Metabolic Disorders Market Pipeline Products
6 Recent Developments
6.1 Product News
6.1.1 May 21, 2025: MedImpact Unveils MedEmpower Fuel AI Plate Scanner
6.1.2 Mar 21, 2025: Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
6.1.3 Jan 06, 2025: Introducing isaac by PreEvnt - Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit
6.2 Strategy And Business Planning
6.2.1 Jul 17, 2024: New Opportunity to Improve Diagnosis Care for People with Cardiovascular-Kidney-Metabolic Syndrome
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Metabolic Disorders Market, United States, Volume (Units), 2018-2033
Table 5: Cholesterol Tests Market, United States, Volume (Units), 2018-2033
Table 6: Diabetes Assays Market, United States, Volume (Units), 2018-2033
Table 7: Metabolic Disorders Market, United States, Average Price ($), 2018-2033
Table 8: Metabolic Disorders Market, United States, Company Share by Revenue ($m), 2024
Table 9: Metabolic Disorders Market Pipeline Products
Table 10: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cholesterol Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Diabetes Assays Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Metabolic Disorders Market, United States, Volume (Units), 2018-2033
Figure 5: Cholesterol Tests Market, United States, Volume (Units), 2018-2033
Figure 6: Diabetes Assays Market, United States, Volume (Units), 2018-2033
Figure 7: Metabolic Disorders Market, United States, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories

Related Topics

Related Reports

United Kingdom Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests - Product Image

United Kingdom Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

  • Report
  • 33 Pages
  • United Kingdom
From
France Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests - Product Image

France Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

  • Report
  • 24 Pages
  • France
From
Brazil Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests - Product Image

Brazil Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

  • Report
  • 32 Pages
  • Brazil
From
Canada Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests - Product Image

Canada Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

  • Report
  • 32 Pages
  • Canada
From
Mexico Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests - Product Image

Mexico Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

  • Report
  • 32 Pages
  • Mexico
From

About the Metabolic Disorder Market

Metabolic disorders are a group of conditions that affect the body's ability to produce or respond to hormones that regulate metabolism. These disorders can affect the body's ability to break down and use carbohydrates, proteins, and fats, as well as its ability to regulate blood sugar levels. Endocrinology is the branch of medicine that deals with the diagnosis and treatment of metabolic disorders. Endocrinologists diagnose and treat a wide range of metabolic disorders, including diabetes, thyroid disorders, and obesity. Metabolic disorders can have a significant impact on a person's quality of life, and can lead to serious health complications if left untreated. Treatment for metabolic disorders typically involves lifestyle changes, such as diet and exercise, as well as medications and other therapies. Companies in the metabolic disorder market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.